首页|超声、糖类抗原125Ⅱ、糖类抗原153Ⅱ联合检查对乳腺癌的诊断价值

超声、糖类抗原125Ⅱ、糖类抗原153Ⅱ联合检查对乳腺癌的诊断价值

扫码查看
目的 探讨超声、糖类抗原125Ⅱ(CA125Ⅱ)、糖类抗原153Ⅱ(CA153Ⅱ)联合检查对乳腺癌的诊断价值.方法 选取93例乳腺影像报告和数据系统(BI-RADS)分级为4级及以上的乳腺疾病患者,所有患者均进行超声、CA125Ⅱ、CA153Ⅱ检查.比较不同超声征象乳腺疾病患者的BI-RADS分级,比较乳腺良性疾病和乳腺癌患者的CA125Ⅱ、CA153Ⅱ水平.采用Kappa检验分析超声、CA125Ⅱ、CA153Ⅱ单独及联合检查诊断乳腺癌的结果与病理检查结果的一致性.绘制受试者工作特征(ROC)曲线,计算曲线下面积(AUC),分析超声、CA125Ⅱ、CA153Ⅱ单独及联合检查对乳腺癌的诊断价值.结果 93例患者中,乳腺癌患者85例,乳腺良性疾病患者8例.不同肿块形态、钙化灶、毛刺征、内部回声、血管征、纵横比乳腺疾病患者的BI-RADS分级比较,差异均有统计学意义(P﹤0.05).乳腺癌患者的CA125Ⅱ、CA153Ⅱ水平均明显高于乳腺良性疾病患者,差异均有统计学意义(P﹤0.01).超声、CA125Ⅱ、CA153Ⅱ联合检查诊断乳腺癌的结果与病理检查结果的一致性Kappa值为0.708,高于三者单独检查的0.472、0.430、0.411.ROC曲线显示,超声、CA125Ⅱ、CA153Ⅱ联合检查诊断乳腺癌的AUC为0.908,高于三者单独检查的0.804、0.855、0.799;超声、CA125Ⅱ、CA153Ⅱ联合检查诊断乳腺癌的灵敏度为0.941,高于三者单独检查的0.859、0.835、0.847.结论 乳腺癌患者中CA125Ⅱ、CA153Ⅱ表达均升高,超声、CA125Ⅱ、CA153Ⅱ联合检查对乳腺癌具有较高的诊断价值.
Diagnostic value of ultrasound,carbohydrate antigen 125Ⅱ and carbohydrate antigen 153Ⅱ in breast cancer
Objective To explore the diagnostic value of ultrasound,carbohydrate antigen 125(CA125)Ⅱ and carbo-hydrate antigen 153(CA153)Ⅱ in breast cancer.Method A total of 93 breast disease patients with breast imaging report-ing and data system(BI-RADS)grade 4 and above were selected.All patients underwent ultrasound,CA125Ⅱ,and CA153Ⅱ detection.The BI-RADS grades of breast disease patients with different ultrasound signs were compared,and the levels of CA125Ⅱand CA153Ⅱ in patients with benign breast disease and breast cancer were compared.The Kappa test was used to analyze the consistency between the results of ultrasound,CA125Ⅱ,CA153Ⅱ single and combined detec-tion in diagnosing breast cancer and the pathological examination results.The receiver operating characteristic(ROC)curve was plotted and the area under the curve(AUC)was calculated to analyze the diagnostic value of ultrasound,CA125Ⅱ and CA153Ⅱ single and combined detection in breast cancer.Result Among the 93 patients,85 patients with breast cancer and 8 patients with benign breast disease.There were statistically significant differences in BI-RADS grades among breast disease patients with different tumor morphology,calcification,burr sign,internal echo,vascular sign and aspect ratio(P<0.05).The levels of CA125Ⅱ and CA153Ⅱ in breast cancer patients were significantly higher than those in patients with benign breast disease,and the differences were statistically significant(P<0.01).The Kappa value between ultrasound,CA125Ⅱ and CA153Ⅱ combined detection and pathological examination in the diagnosis of breast cancer was 0.708,which was higher than 0.472,0.430 and 0.411 of the single detection.ROC curve showed that the AUC of ultra-sound,CA125Ⅱ and CA153Ⅱ combined detection in the diagnosis of breast cancer was 0.908,which was higher than 0.804,0.855 and 0.799 of the single detection.The sensitivity of ultrasound,CA125Ⅱ and CA153Ⅱ combined detec-tion in the diagnosis of breast cancer was 0.941,which was higher than 0.859,0.835 and 0.847 of the single detection.Conclusion The expression of CA125Ⅱ and CA153Ⅱ are higher in breast cancer patients,and ultrasound,CA125Ⅱ and CA153Ⅱ combined detection had high diagnostic value for breast cancer.

ultrasoundcarbohydrate antigen 125Ⅱcarbohydrate antigen 153Ⅱbreast cancerdiagnostic value

王琼、彭红玲、贺敏

展开 >

萍乡市妇幼保健院超声科,江西 萍乡 337000

超声 糖类抗原125Ⅱ 糖类抗原153Ⅱ 乳腺癌 诊断价值

江西省卫生健康委科技计划项目

202140487

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(4)
  • 19